Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Ph.D., Duke University 2014
• Research
• 

  Selected Grants

  • Area A: Development of genetically tractable, driver gene-syngeneic brain tumor models for pre-clinical adoptive TCR-T therapy awarded by National Institutes of Health 2017 - 2020
  • Poliovirus Vector-Delivered Tumor-Associated Antigens for Glioma Immunotherapy 2017 - 2020
  • The Role of IDH1 Mutations in Gliomagenesis and Metabolism awarded by National Institutes of Health 2009 - 2020
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Hansen, Landon J., Ran Sun, Rui Yang, Simranjit X. Singh, Lee H. Chen, Christopher J. Pirozzi, Casey J. Moure, et al. “MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation..” Cancer Res 79, no. 13 (July 1, 2019): 3383–94. https://doi.org/10.1158/0008-5472.CAN-18-1010.
       Full Text  Link to Item
    • Liu, Yang, Austin B. Carpenter, Christopher J. Pirozzi, Hsiangkuo Yuan, Matthew S. Waitkus, Zhengyuan Zhou, Landon Hansen, et al. “Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe..” Nanotechnology 30, no. 27 (March 11, 2019). https://doi.org/10.1088/1361-6528/ab0e9c.
       Full Text  Link to Item
    • Pirozzi, Christopher J., and Hai Yan. “Improved grading of IDH-mutated astrocytic gliomas..” Nat Rev Neurol 14, no. 7 (July 2018): 383–84. https://doi.org/10.1038/s41582-018-0019-6.
       Full Text  Link to Item
    • Waitkus, Matthew S., Christopher J. Pirozzi, Casey J. Moure, Bill H. Diplas, Landon J. Hansen, Austin B. Carpenter, Rui Yang, et al. “Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities..” Cancer Res 78, no. 1 (January 1, 2018): 36–50. https://doi.org/10.1158/0008-5472.CAN-17-1352.
       Full Text  Link to Item
    • Yang, Rui, Lee H. Chen, Landon J. Hansen, Austin B. Carpenter, Casey J. Moure, Heng Liu, Christopher J. Pirozzi, et al. “Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation..” Cancer Res 77, no. 22 (November 15, 2017): 6097–6108. https://doi.org/10.1158/0008-5472.CAN-17-1018.
       Full Text  Link to Item
    • Pirozzi, Christopher J., Austin B. Carpenter, Matthew S. Waitkus, Catherine Y. Wang, Huishan Zhu, Landon J. Hansen, Lee H. Chen, et al. “Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression..” Mol Cancer Res 15, no. 5 (May 2017): 507–20. https://doi.org/10.1158/1541-7786.MCR-16-0485.
       Full Text  Link to Item
    • Killela, Patrick J., Christopher J. Pirozzi, Patrick Healy, Zachary J. Reitman, Eric Lipp, B Ahmed Rasheed, Rui Yang, et al. “Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas..” Oncotarget 5, no. 6 (March 30, 2014): 1515–25. https://doi.org/10.18632/oncotarget.1765.
       Full Text  Open Access Copy  Link to Item
    • Killela, Patrick J., Christopher J. Pirozzi, Zachary J. Reitman, Sian Jones, B Ahmed Rasheed, Eric Lipp, Henry Friedman, et al. “The genetic landscape of anaplastic astrocytoma..” Oncotarget 5, no. 6 (March 30, 2014): 1452–57. https://doi.org/10.18632/oncotarget.1505.
       Full Text  Link to Item
    • Reitman, Zachary J., Christopher J. Pirozzi, and Hai Yan. “Promoting a new brain tumor mutation: TERT promoter mutations in CNS tumors..” Acta Neuropathol 126, no. 6 (December 2013): 789–92. https://doi.org/10.1007/s00401-013-1207-5.
       Full Text  Link to Item
    • Guo, Changcun, Lee H. Chen, Yafen Huang, Chun-Chi Chang, Ping Wang, Christopher J. Pirozzi, Xiaoxia Qin, et al. “KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation..” Oncotarget 4, no. 11 (November 2013): 2144–53. https://doi.org/10.18632/oncotarget.1555.
       Full Text  Link to Item
    • Pirozzi, Christopher J., Zachary J. Reitman, and Hai Yan. “Releasing the block: setting differentiation free with mutant IDH inhibitors..” Cancer Cell 23, no. 5 (May 13, 2013): 570–72. https://doi.org/10.1016/j.ccr.2013.04.024.
       Full Text  Link to Item
    • Jin, Genglin, Christopher J. Pirozzi, Lee H. Chen, Giselle Y. Lopez, Christopher G. Duncan, Jie Feng, Ivan Spasojevic, Darell D. Bigner, Yiping He, and Hai Yan. “Mutant IDH1 is required for IDH1 mutated tumor cell growth..” Oncotarget 3, no. 8 (August 2012): 774–82. https://doi.org/10.18632/oncotarget.577.
       Full Text  Open Access Copy  Link to Item
    • Jiao, Yuchen, Patrick J. Killela, Zachary J. Reitman, Ahmed B. Rasheed, Christopher M. Heaphy, Roeland F. de Wilde, Fausto J. Rodriguez, et al. “Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas..” Oncotarget 3, no. 7 (July 2012): 709–22. https://doi.org/10.18632/oncotarget.588.
       Full Text  Open Access Copy  Link to Item
    • Guo, Changcun, Christopher J. Pirozzi, Giselle Y. Lopez, and Hai Yan. “Isocitrate dehydrogenase mutations in gliomas: mechanisms, biomarkers and therapeutic target..” Curr Opin Neurol 24, no. 6 (December 2011): 648–52. https://doi.org/10.1097/WCO.0b013e32834cd415.
       Full Text  Open Access Copy  Link to Item

  • Book Sections

    • Chandramohan, V., L. Sanchez-Perez, Y. He, C. J. Pirozzi, K. L. Congdon, and D. D. Bigner. “Preclinical Immunotherapeutic Animal Models for Brain Tumors.” In Translational Immunotherapy of Brain Tumors, 111–47, 2017. https://doi.org/10.1016/B978-0-12-802420-1.00006-5.
       Full Text
    • Pirozzi, C. J., A. B. Carpenter, T. Hennika, O. J. Becher, and H. Yan. “Tumor-Specific Mutations in Gliomas and their Implications for Immunotherapy.” In Translational Immunotherapy of Brain Tumors, 83–107, 2017. https://doi.org/10.1016/B978-0-12-802420-1.00005-3.
       Full Text

  • Conference Papers

    • Pirozzi, Christopher J., Catherine Y. Wang, Austin B. Carpenter, Huishan Zhu, Paula K. Greer, Roger E. McLendon, Darell D. Bigner, Yiping He, and Hai Yan. “Abstract 63: Driving brain tumorigenesis: Generation of a mutant IDH1 mouse model of progressive glioma.” In Tumor Biology. American Association for Cancer Research, 2014. https://doi.org/10.1158/1538-7445.am2014-63.
       Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.